[go: up one dir, main page]

SE9601901D0 - Quinine antagonists for use as a pharmaceutical - Google Patents

Quinine antagonists for use as a pharmaceutical

Info

Publication number
SE9601901D0
SE9601901D0 SE9601901A SE9601901A SE9601901D0 SE 9601901 D0 SE9601901 D0 SE 9601901D0 SE 9601901 A SE9601901 A SE 9601901A SE 9601901 A SE9601901 A SE 9601901A SE 9601901 D0 SE9601901 D0 SE 9601901D0
Authority
SE
Sweden
Prior art keywords
antagonists
quinine
pharmaceutical
moracella
yersinia
Prior art date
Application number
SE9601901A
Other languages
English (en)
Inventor
Lars Bjoerck
Ulf Sjoebring
Nasr Abdelhakim Ben
Arne Olsen
Mattias Collin
Heiko Herwald
Werner Mueller-Esterl
Original Assignee
Lars Bjoerck
Ulf Sjoebring
Nasr Abdelhakim Ben
Arne Olsen
Mattias Collin
Heiko Herwald
Werner Mueller Esterl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars Bjoerck, Ulf Sjoebring, Nasr Abdelhakim Ben, Arne Olsen, Mattias Collin, Heiko Herwald, Werner Mueller Esterl filed Critical Lars Bjoerck
Priority to SE9601901A priority Critical patent/SE9601901D0/sv
Publication of SE9601901D0 publication Critical patent/SE9601901D0/sv
Priority to PCT/SE1997/000825 priority patent/WO1997044353A1/en
Priority to AU29857/97A priority patent/AU2985797A/en
Priority to US09/194,098 priority patent/US6221845B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE9601901A 1996-05-20 1996-05-20 Quinine antagonists for use as a pharmaceutical SE9601901D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9601901A SE9601901D0 (sv) 1996-05-20 1996-05-20 Quinine antagonists for use as a pharmaceutical
PCT/SE1997/000825 WO1997044353A1 (en) 1996-05-20 1997-05-20 Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections
AU29857/97A AU2985797A (en) 1996-05-20 1997-05-20 Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections
US09/194,098 US6221845B1 (en) 1996-05-20 1997-05-20 Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601901A SE9601901D0 (sv) 1996-05-20 1996-05-20 Quinine antagonists for use as a pharmaceutical

Publications (1)

Publication Number Publication Date
SE9601901D0 true SE9601901D0 (sv) 1996-05-20

Family

ID=20402616

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601901A SE9601901D0 (sv) 1996-05-20 1996-05-20 Quinine antagonists for use as a pharmaceutical

Country Status (3)

Country Link
US (1) US6221845B1 (sv)
AU (1) AU2985797A (sv)
SE (1) SE9601901D0 (sv)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845242A (en) 1987-04-28 1989-07-04 Georgia Tech Research Corporation Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
KR960009766B1 (ko) 1986-09-10 1996-07-24 니혼 소오끼 세이야꾸 가부시기가이샤 생리 활성물질 측정법
JPH06508116A (ja) * 1991-04-01 1994-09-14 コルテク，インコーポレイテッド ブラジキニンアンタゴニスト
US5416191A (en) * 1991-04-01 1995-05-16 Cortech, Inc. Bradykinin antagonists
WO1992022320A1 (en) 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE69534186T2 (de) * 1994-09-14 2006-03-09 Baylor College Of Medicine, Houston Impfstoff gegen Streptokokkeninfektionen der Gruppe A

Also Published As

Publication number Publication date
US6221845B1 (en) 2001-04-24
AU2985797A (en) 1997-12-09

Similar Documents

Publication Publication Date Title
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
ATE219684T1 (de) Anti gram positive bakterielle verfahren und mittel
DE60334016D1 (de) Antibakterielle mittel
TW200507841A (en) Antibacterial agents
MY131300A (en) Antibacterial agents
WO2004058144A3 (en) Antibacterial agents
CA2031803A1 (en) Improvements in or relating to glycopeptide deriveratives
BE2011C037I2 (sv)
WO1989006649A3 (en) Antibacterial agents
DE60331849D1 (de) Antibakterielle wirkstoffe
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
CA2101447A1 (en) 3-difluoromethylpyrazolecarboxamide fungicides
YU51095A (sh) Benzokazolil - i benzotiazolil-oksazo lidinoni
RU93004457A (ru) 1-карба-(1-детиа)-цефемы и промежуточные продукты для их получения
AU2003294565A8 (en) Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
SE9601901D0 (sv) Quinine antagonists for use as a pharmaceutical
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
AR021463A1 (es) Antibiotico de piridona con perfil de seguridad mejorado
IT8821731A0 (it) Kit per la riattivazione di colture microbiche disidratate, in particolare di batteri.
ES8702428A1 (es) Un metodo para producir antibiotico tan-588 y-o n-desacetil-antibiotico tan-588
BG42676A3 (en) Method for preparang derivatives of 6- aminoalkyl- penicillanic acid
ES8205809A1 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas
Morley et al. Treatment of Legionella lung abscess: unanswered questions?
ES8707708A1 (es) Un metodo para producir antibioticos tan - 749 a, b, c y d o sus sales